Mary Beth Harler, new head of IGM autoimmunity and inflammation department (Bristol Myers Squibb)
Top Sanofi vaccine execs, Bristol Myers vet chart new path for IGM's antibodies in infectious diseases, autoimmunity
When IGM Biosciences made its public debut two years ago, the S-1 pitch was heavily centered on how its engineered IgM antibodies could make potent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
